Front-page

Cancer Watch

Breakthroughs

Feature

New Frontiers

Pediatric Frontiers

Health Unusual

Industry News

UN Health

Organized Medicine

 

CME Calendar

November

December

January

February

March

powered by: FreeFind

Current Issue

September 2002

More Issues

 

 
 
 

Industry News

UST Hospital Opens MRI Section

The University of Santo Tomas Hospital now has a new service, part of its division of radiological sciences, the section of Magnetic Resonance Imaging (MRI). Inaugurated last August 15, the facility upholds the hospital's role as one of the country's leading tertiary hospitals.

More on this Story

Dolly Creator Closes Shop

The British firm that created the world's first cloned sheep, Dolly, is closing its stem cell business after it failed to find a buyer for it. 

More on this Story

Postgrad Course at JRMMC

New trends and techniques in facial aesthethic surgery will be the subject of the seventh annual postgraduate course of the Jose Reyes Memorial Medical Center's Department of Otorhinolaryngology-Head and Neck Surgery slated November 11-12.    

More on this Story

Pfizer Sues Rivals Over Viagra Patent

Pfizer has filed two separate lawsuits against rivals Eli Lilly, Icoa Corp, GlaxoSmithKline, and Bayer alleging violation of its patent for Viagra.

More on this Story

French, US Researchers Fight Over Cancer Gene

Three French medical institutes, reviving a conflict over the right to patent gene-related discoveries, vowed to fight a new claim by an American firm on a gene linked to breast and ovarian cancer.

More on this Story

MSD Introduces Vioxx Once-Daily Formulation

Merck Sharp & Dohme Philippines recently introduced a once-daily formulation for the cyclooxygenase 2 (COX-2) inhibitor rofecoxib (Vioxx Forte).

More on this Story

Aventis Pharma Launches ActNow

Aventis Pharma Philippines, in cooperation with the Osteoporosis Society of the Philippines, launched in October the first comprehensive management program for patients suffering from osteoporosis.

More on this Story

10mg Tritace Now Available

Aventis Pharma Philippines recently launched the 10mg formulation for ramipril (Tritace).

More on this Story

 

 

Updated last February 10, 2003 , Developed and Maintained by JML Internet Solutions
Best viewed with Microsoft Internet Explorer 5 and up at 800x600 resolution

Notice: The articles in this website are meant for information and education purposes only and are not intended to encourage self-diagnosis and self-medication. Readers should consult their physicians for professional medical advice. 

Copyright © 2002, Medical Observer. All rights reserved.